Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning

被引：31
|
作者：
Askaa, B. [1 ]
Fischer-Nielsen, A. [2 ]
Vindelov, L. [1 ]
Haastrup, E. K. [2 ]
Sengelov, H. [1 ]
机构：
[1] Natl Univ Hosp, Dept Hematol, Copenhagen, Denmark
[2] Natl Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷 / 05期
关键词：
BLOOD-CELLS; FAILURE; MARROW;
D O I：
10.1038/bmt.2014.5
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：720 / 721
页数：2
相关论文
共 50 条
  • [31] CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation
    Mainardi, Chiara
    Ebinger, Martin
    Enkel, Sigrid
    Feuchtinger, Tobias
    Teltschik, Heiko-Manuel
    Eyrich, Matthias
    Schumm, Michael
    Rabsteyn, Armin
    Schlegel, Patrick
    Seitz, Christian
    Schwarze, Carl-Phillip
    Mueller, Ingo
    Greil, Johann
    Bader, Peter
    Schlegel, Paul-Gerhardt
    Martin, David
    Holzer, Ursula
    Doering, Michaela
    Handgretinger, Rupert
    Lang, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (01) : 90 - 99
  • [32] Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation
    Haen, Sebastian P.
    Schumm, Michael
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    Vogel, Wichard
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (12) : 2241 - 2251
  • [33] Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation
    Sebastian P. Haen
    Michael Schumm
    Christoph Faul
    Lothar Kanz
    Wolfgang A. Bethge
    Wichard Vogel
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2241 - 2251
  • [34] Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Malard, F.
    Shah, G. L.
    Seier, K.
    Cho, C.
    Devlin, S. M.
    Maloy, M.
    Borrill, T.
    Palazzo, M.
    van den Brink, M.
    Perales, M-A
    BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S29
  • [35] CD34 Selected Stem Cells Boosts Are Safe and Effective for Patients with Poor Bone Marrow Function After Allogeneic Hematopoietic Cell Transplantation.
    Haen, Sebastian P.
    Schumm, Michael
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    Vogel, Wichard
    BLOOD, 2012, 120 (21)
  • [36] CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma
    Smith, Eric
    Devlin, Sean M.
    Kosuri, Satyajit
    Orlando, Evelyn
    Landau, Heather
    Lesokhin, Alex M.
    Chung, David J.
    Hassoun, Hani
    Lendvai, Nikoletta
    Landgren, Ola
    Giralt, Sergio
    Chari, Ajai
    Jagannath, Sundar
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) : 258 - 267
  • [37] Poor graft function following allogeneic stem cell transplantation: High rate of complete recovery using boost CD34+selected peripheral blood stem cells without further conditioning
    Larocca, A
    Bruno, B
    Di Grazia, C
    Gualandi, F
    Occhini, D
    Raiola, AM
    Dominietto, A
    Bregante, S
    Lamparelli, T
    Van Lint, MT
    Pogliani, EM
    Bacigalupo, A
    BLOOD, 2005, 106 (11) : 406B - 406B
  • [38] CD34+selected stem cell boosts can improve poor graft function after allogeneic stem cell transplantation in pediatric patients
    Lang, P.
    Mainardi, C.
    Ebinger, M.
    Enkel, S.
    Teltschik, H-M
    Schumm, M.
    Feuchtinger, T.
    Rabsteyn, A.
    Schlegel, P.
    Seitz, C.
    Schwarze, C-P
    Mueller, I.
    Greil, J.
    Bader, P.
    Schlegel, P-G
    Holzer, U.
    Doering, M.
    Handgretinger, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S135 - S137
  • [39] CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease
    Rangarajan, Hemalatha G.
    Crowell, Sara A.
    Towerman, Alison S.
    Shenoy, Shalini S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1592 - 1594
  • [40] Eltrombopag Improves Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Koshy, Nebu
    Master, Samip
    Leary, Cheri
    Bozeman, Amy
    Peyton-Thomas, Breanne
    Peddi, Prakash
    Devarakonda, Srinivas
    Mansour, Richard
    Mills, Glenn
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S284 - S286
12345